Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
116
Frequently Asked Questions
What is Market Cap of Praxis Precision Medicines Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Praxis Precision Medicines Inc market cap is $1.14B.
What is the 52-week high for Praxis Precision Medicines Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Praxis Precision Medicines Inc 52 week high is $91.83 as of October 06, 2025.
What is the 52-week low for Praxis Precision Medicines Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Praxis Precision Medicines Inc 52 week low is $26.70 as of October 06, 2025.
What is Praxis Precision Medicines Inc stock price today?
Praxis Precision Medicines Inc stock price today is $50.90.
What was Praxis Precision Medicines Inc stock price yesterday?
Praxis Precision Medicines Inc stock price yesterday was $54.38.
What is the PE ratio of Praxis Precision Medicines Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Praxis Precision Medicines Inc’s P/E ratio is -4.43.
What is the Price-to-Book ratio of Praxis Precision Medicines Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Praxis Precision Medicines Inc P/B ratio is 2.8306.
What is the 50-day moving average of Praxis Precision Medicines Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Praxis Precision Medicines Inc 50-day moving average is $47.82.
How many employess does Praxis Precision Medicines Inc has?
